Polypeptides, antibody variable domains and antagonists

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/28 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) C12N 15/13 (2006.01)

Patent

CA 2688434

The invention relates to anti-TNFR1 polypeptides and antibody single variable domains (dAbs) that are resistant to degradation by a protease, as well as antagonists comprising these. The polypeptides, dAbs and antagonists are useful for as therapeutics and/or prophylactics that are likely to encounter proteases when administered to a patient, for example for pulmonary administration, oral administration, delivery to the lung and delivery to the GI tract of a patient, as well as for treating inflammatory disease, such as arthritis or COPD.

L'invention porte sur des polypeptides anti-TNFR1 et sur des domaines variables uniques d'anticorps (dAbs) qui sont résistants à la dégradation par une protéase, ainsi que sur des antagonistes les comprenant. Les polypeptides, les dAb et les antagonistes sont utiles en tant qu'agent thérapeutiques et/ou prophylactiques qui sont susceptibles de rencontrer des protéases lorsqu'ils sont administrés à un patient, par exemple, pour une administration pulmonaire, une administration orale, une administration au poumon et une administration au tractus gastro-intestinal d'un patient, ainsi que pour un traitement d'une maladie inflammatoire, telle que l'arthrite ou la broncho-pneumopathique chronique obstructive (COPD).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Polypeptides, antibody variable domains and antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptides, antibody variable domains and antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides, antibody variable domains and antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2036622

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.